Enhanced Oral Delivery of Exenatide: Optimizing Lipid-Based Formulations & Enteric Protection
Time: 12:00 pm
day: Day One
Details:
- Showcasing in vitro and in vivo data from healthy volunteers to highlight the consistent and effective delivery of the payload to the small intestine using Capsugel® Enprotect® capsules, regardless of dosing conditions
- Designing advanced lipid-based formulations with permeation enhancers to improve exenatide’s resistance to proteases and enhance its intestinal absorption as a model GLP-1 receptor agonist peptide
- Tailoring the enteric properties of Capsugel® Enprotect® capsules to the specific requirements of lipid-based formulations and permeation enhancers through our proprietary bilayer manufacturing technology
